We specialize in early identification of cardiovascular risk through advanced imaging and biomarker diagnostics. Our clinical prevention programs emphasize the use of coronary CT angiography (CTA), calcium scoring, and other non-invasive screening modalities to detect subclinical atherosclerosis and vascular inflammation — conditions that are often missed using traditional assessment tools. These screenings are particularly vital for South Asians, who may develop high-risk plaque formations in the absence of typical risk factors like obesity or smoking. Early detection allows for timely intervention and individualized care planning.
The use of coronary CT angiography (CTA), calcium scoring, and other screening methods to detect dangerous plaque buildup before it’s too late is crucial— particularly in younger adults who might otherwise be overlooked.
We specialize in early identification of cardiovascular risk through advanced imaging and biomarker diagnostics. Our clinical prevention programs emphasize the use of coronary CT angiography (CTA), calcium scoring, and other non-invasive screening modalities to detect subclinical atherosclerosis and vascular inflammation — conditions that are often missed using traditional assessment tools. These screenings are particularly vital for South Asians, who may develop high-risk plaque formations in the absence of typical risk factors like obesity or smoking. Early detection allows for timely intervention and individualized care planning.
Our research explores how early insulin resistance behaves in South Asians and how interventions — lifestyle or clinical — can delay or prevent metabolic decline.
Unlike other populations, South Asians have a disproportionate tendency to accumulate visceral fat — fat that surrounds internal organs — even when body weight appears within a “healthy” range. This form of adiposity is strongly linked to systemic inflammation, metabolic syndrome, and increased cardiometabolic risk. LPS Health is working to quantify and characterize visceral fat patterns in South Asians, with the goal of developing more accurate screening protocols and tailored interventions that reflect this hidden burden.
We study visceral adiposity patterns in South Asians to help redefine what “at-risk” really means — and ensure better screening guidelines for our population.
Elevated lipoprotein(a), or Lp(a), is a genetically inherited risk factor that significantly increases the likelihood of atherosclerotic cardiovascular disease. While Lp(a) is increasingly recognized in broader cardiology, its prevalence and impact in South Asian populations remain under-researched. At LPS Health, we are committed to advancing understanding of Lp(a)-associated risk in this community — including how it interacts with other metabolic and inflammatory pathways — to better inform future screening and treatment guidelines.
We’re researching how Lp(a) disproportionately affects South Asians, how it accelerates heart risk, and how we can bring it into the spotlight of routine prevention.
Your health journey starts with understanding where you stand. Our simple Cardiometabolic Health Test helps you check key risk factors like blood pressure, blood sugar, and cholesterol. It’s a quick, informative way to gain insights and take proactive steps toward feeling your best—with support every step of the way.